Hermetica Superfood Encyclopedia
The Short Answer
Bilobalide is a sesquiterpene lactone found in Ginkgo biloba that provides neuroprotection by reducing glutamate excitotoxicity and modulating calcium channels. This bioactive compound activates the AMPK/SIRT1 pathway to reduce inflammation and promote cellular autophagy.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordbilobalide benefits
Synergy Pairings3
Bilobalide (Sesquiterpene Lactone) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Bilobalide is a unique sesquiterpene trilactone isolated primarily from the leaves of Ginkgo biloba L., a tree native to China. It constitutes a key component of standardized Ginkgo biloba extracts (e.g., EGb 761), typically extracted via solvent methods from dried leaves followed by purification. In standardized extracts, bilobalide comprises 2.6-3.2% of the total content.
“Bilobalide itself is not independently documented in traditional medicine but derives from Ginkgo biloba leaves used for over 1,000 years in Traditional Chinese Medicine. Historical TCM contexts emphasized Ginkgo leaf tea for cognitive enhancement, circulatory disorders, and asthma, from which bilobalide was later isolated in modern studies.”Traditional Medicine
Scientific Research
No human clinical trials specifically on isolated bilobalide were identified; evidence is limited to preclinical animal and in vitro studies. A double-blind, randomized cross-over study (PMC9347086) evaluated a liposomal Ginkgo biloba extract containing bilobalide, confirming safety and superior absorption but not efficacy outcomes for bilobalide specifically. Preclinical studies include rat PTOA models (PMC8905364) showing reduced inflammation at 5-10 mg/kg and mouse stroke models (PMC3217178) demonstrating neuroprotection at 10 mg/kg.
Preparation & Dosage
Traditional preparation
No clinically studied dosages exist for isolated bilobalide in humans. Animal studies used 5-10 mg/kg intraperitoneally. In standardized Ginkgo biloba extracts (EGb 761), bilobalide is present at 2.6-3.2 mg per 120 mg extract dose. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Bilobalide is a pure isolated sesquiterpene lactone compound, not a whole food ingredient, and therefore has no macronutrient, micronutrient, fiber, or protein content. As a bioactive compound, its profile is defined entirely by its molecular and pharmacological characteristics: Molecular formula C15H18O8, molecular weight 326.29 g/mol. It is one of the primary bioactive constituents of Ginkgo biloba leaf extract, typically comprising 2-3% of standardized Ginkgo biloba extract (GBE) by weight (e.g., in EGb 761 standardized extract, bilobalide content is approximately 2.6-3.2% of total extract weight). In raw Ginkgo biloba dried leaves, bilobalide concentrations range from approximately 0.5-1.2 mg/g dry weight. As a sesquiterpene trilactone, it contains three lactone rings contributing to its biological activity. Bioavailability: Oral bioavailability is estimated at approximately 70-80% in human pharmacokinetic studies, with peak plasma concentrations (Tmax) reached at 1-3 hours post-ingestion. Half-life is approximately 3-4 hours. It readily crosses the blood-brain barrier due to its lipophilic character, which underlies its neuroprotective effects. It is not a source of vitamins or minerals. Typical research doses range from 40-120 mg of standardized extract delivering proportional bilobalide amounts.
How It Works
Mechanism of Action
Bilobalide activates the AMPK/SIRT1/mTOR signaling cascade, which promotes chondrocyte autophagy and reduces inflammatory cytokines. The compound inhibits excessive glutamate release at synapses by modulating presynaptic calcium channels, preventing excitotoxic neuronal damage. Additionally, bilobalide stabilizes mitochondrial membranes and reduces oxidative stress through enhanced antioxidant enzyme activity.
Clinical Evidence
Animal studies demonstrate bilobalide reduces osteoarthritis pain and inflammation markers through AMPK/SIRT1 pathway activation. Mouse stroke models show 4-10 fold reduction in glutamate release with bilobalide treatment, providing significant neuroprotection. The compound promotes beneficial chondrocyte autophagy while reducing inflammatory cytokine expression in joint tissues. However, human clinical trials specifically examining isolated bilobalide remain limited, with most evidence coming from Ginkgo biloba extract studies.
Safety & Interactions
Bilobalide appears well-tolerated in animal studies with no significant adverse effects reported at therapeutic doses. As a component of Ginkgo biloba, potential interactions may include increased bleeding risk when combined with anticoagulant medications like warfarin. Pregnant and breastfeeding women should avoid bilobalide supplements due to insufficient safety data. Individuals with epilepsy should exercise caution as high doses of Ginkgo compounds may lower seizure threshold.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
BBGinkgolide CTrilactone sesquiterpeneGinkgo trilactoneEGb 761 componentBai Guo Ye extract componentMaidenhair tree lactone
Frequently Asked Questions
How much bilobalide is in ginkgo biloba extract?
Standardized ginkgo biloba extracts typically contain 2.6-3.2% bilobalide by weight. A 120mg dose of EGb 761 extract provides approximately 3-4mg of bilobalide along with other active compounds.
Can bilobalide help with Alzheimer's disease?
Animal studies suggest bilobalide may protect against neurodegeneration through glutamate modulation and AMPK activation. However, human clinical trials specifically testing bilobalide for Alzheimer's prevention or treatment are currently lacking.
What is the difference between bilobalide and ginkgolides?
Bilobalide is a sesquiterpene lactone that primarily affects glutamate signaling and cellular autophagy. Ginkgolides are diterpene lactones that mainly inhibit platelet-activating factor (PAF) and have stronger anticoagulant properties.
Does bilobalide cross the blood-brain barrier?
Yes, bilobalide readily crosses the blood-brain barrier due to its lipophilic sesquiterpene structure. This allows the compound to directly interact with brain neurons and provide neuroprotective effects against excitotoxicity.
How long does bilobalide take to show effects?
In animal stroke models, bilobalide shows neuroprotective effects within hours of administration. For anti-inflammatory effects in osteoarthritis, benefits may develop over several weeks of consistent supplementation based on animal study protocols.
Is bilobalide safe to take with blood thinners or anticoagulant medications?
Bilobalide itself has not been documented to cause significant anticoagulant effects, but ginkgo biloba extracts containing bilobalide may have mild antiplatelet activity. It is advisable to consult a healthcare provider before combining bilobalide supplements with blood thinners like warfarin or aspirin to avoid potential additive effects. Most clinical studies of ginkgo extracts in combination with anticoagulants have not reported serious interactions, but individual sensitivity varies.
What is the typical dosage range of bilobalide in clinical studies on joint health and osteoarthritis?
Clinical and preclinical studies examining bilobalide's effects on osteoarthritis have typically used ginkgo biloba extracts standardized to contain 24% ginkgolides and 6% bilobalide, though isolated bilobalide dosing is less commonly reported in human trials. Animal models showing efficacy for joint inflammation and chondrocyte protection have used doses equivalent to 10–50 mg/kg, which would translate to roughly 700–3,500 mg in humans, though this requires clinical validation. Most commercial ginkgo supplements deliver bilobalide in the range of 2–6 mg per serving, considerably lower than doses used in animal osteoarthritis research.
How does bilobalide compare to other ginkgo phytochemicals for neuroprotection after stroke?
Bilobalide demonstrates neuroprotective effects through glutamate attenuation (4–10 fold reduction in mouse stroke models), while ginkgolides (particularly ginkgolide B) primarily work by inhibiting platelet-activating factor and improving blood flow. Bilobalide's direct action on synaptic glutamate release makes it complementary to ginkgolides' vascular and antiplatelet mechanisms, which is why standardized ginkgo extracts containing both compounds may offer synergistic stroke protection. The combination of bilobalide and ginkgolides in clinical extracts appears to provide more comprehensive neuroprotection than either component alone.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w bilobalide curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
